The Use of Single-Agent Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma Patients With Underlying Child-Pugh B Liver Cirrhosis: A Retrospective Analysis of Efficacy, Safety, and Survival Benefits
JOANNE CHIU, YUEN FONG TANG, TATFAN, Sheung, YAU, Thomas, YAO, Tzy-Jyun, WONG, Ashley, HILDA WONG, LEUNG, Roland, CHAN, Pierre, TAN TO CHEUNG, CHAN, Albert C, PANG, Roberta
Published in Cancer (01.11.2012)
Published in Cancer (01.11.2012)
Get full text
Journal Article
The use of single‐agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child‐Pugh B liver cirrhosis
Chiu, Joanne, Tang, Yuen Fong, Yao, Tzy‐Jyun, Wong, Ashley, Wong, Hilda, Leung, Roland, Chan, Pierre, Cheung, Tan To, Chan, Albert C., Pang, Roberta, Fan, Sheung‐Tat, Poon, Ronnie, Yau, Thomas
Published in Cancer (01.11.2012)
Published in Cancer (01.11.2012)
Get full text
Journal Article
The Outcomes and Safety of Single‐Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC)
Wong, Hilda, Tang, Yuen Fong, Yao, Tzy‐Jyun, Chiu, Joanne, Leung, Roland, Chan, Pierre, Cheung, Tan To, Chan, Albert C., Pang, Roberta W., Poon, Ronnie, Fan, Sheung‐Tat, Yau, Thomas
Published in The oncologist (Dayton, Ohio) (01.12.2011)
Published in The oncologist (Dayton, Ohio) (01.12.2011)
Get full text
Journal Article